Synapticure Raises $25 Million To Expand Virtual Care For Consumers With Neurodegenerative Diseases

Virtual specialty care company Synapticure raised $25 million in a Series A funding round. It plans to use the funds to increase access to care for people in the United States diagnosed with a variety of neurodegenerative diseases that result in cognitive, neuromuscular, and movement disorders. The round was led by B Capital, with investments from CommonSpirit Health, CVS Health Ventures, Google Ventures, Optum Ventures, Rock Health Capital, RA Capital Management, and Nexus NeuroTech.

Synapticure launched operations in 2022 as a specialty care platform to address the unmet care needs of consumers living with neurodegenerative diseases and their caregivers. It . . .